During the past decade, Bay Area Arthritis and Osteoporosis conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bay Area Arthritis and Osteoporosis" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bay Area Arthritis and Osteoporosis" #1 collaborator was "Galapagos NV" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Bay Area Arthritis and Osteoporosis" are "Systemic Lupus Erythematosus" (4 trials), "Lupus Erythematosus, Systemic" (2 trials), "Psoriatic Arthritis" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Postmenopausal Osteoporosis" (1 trials). Many other conditions were trialed in "Bay Area Arthritis and Osteoporosis" in a lesser frequency.

Most popular intervention types in "Bay Area Arthritis and Osteoporosis" are "Drug" (10 trials), "Biological" (3 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "GDC-0853" (2 trials), "Nipocalimab" (2 trials), "Adalimumab" (1 trials) and "Afimetoran" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bay Area Arthritis and Osteoporosis" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Bay Area Arthritis and Osteoporosis". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Bay Area Arthritis and Osteoporosis, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Bay Area Arthritis and Osteoporosis, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".